A $6.3 Million Endowed Directorship at Rutgers Cancer Institute Recognizes Visionary Oncology Leader



Bolstered by $6.3 million raised in donations, the Rutgers Board of Governors approved the establishment of the William Hait Endowed Directorship at Rutgers Cancer Institute. Moving forward, the director of Rutgers Cancer Institute will be known as the William Hait Director.

The Bristol-Myers Squibb Children’s Hospital and Rutgers Cancer Institute Dedicate New Pediatric Bone Marrow Transplantation and Cellular Therapy Program

The Bristol-Myers Squibb Children’s Hospital at Robert Wood Johnson University Hospital and Rutgers Cancer Institute recently dedicated the new Pediatric Bone Marrow Transplantation and Cellular Therapy Program recognizing the many donors who supported the program.

Cooperman Barnabas Medical Center Announces Historic Gift from Andrea and Anthony Melchiorre to Support New Cancer Center

Cooperman Barnabas Medical Center, an RWJBarnabas Health facility, has received a visionary gift of $30 million from Andrea and Anthony Melchiorre to support the new multidisciplinary standalone cancer center now under construction on the hospital campus in Livingston, New Jersey.

Immunotherapy Continues to Shape the future of Cancer Treatment

Immunotherapy, a type of cancer treatment that uses a person’s own immune system to attack cancer cells, is continuing to transform cancer treatment and care. Christian S. Hinrichs, MD, chief of the Section of Cancer Immunotherapy and co-director of the Duncan and Nancy MacMillan Cancer Immunology and Metabolism Center of Excellence at Rutgers Cancer Institute and RWJBarnabas Health, shares the basics of immunotherapy, who can benefit from it, and what the future holds for this groundbreaking treatment.